IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 137 filers reported holding IMMUNOGEN INC in Q1 2017. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $91,864,371 | -13.3% | 5,788,555 | +3.1% | 0.01% | -11.1% |
Q2 2023 | $105,912,442 | +1049.9% | 5,612,742 | +134.0% | 0.01% | – |
Q1 2023 | $9,210,426 | +55.1% | 2,398,548 | +100.3% | 0.00% | -100.0% |
Q4 2022 | $5,938,226 | +12.4% | 1,197,223 | +8.3% | 0.00% | 0.0% |
Q3 2022 | $5,285,000 | +6.6% | 1,105,729 | +0.3% | 0.00% | – |
Q2 2022 | $4,959,000 | -91.4% | 1,101,983 | -90.9% | 0.00% | -100.0% |
Q1 2022 | $57,474,000 | -36.9% | 12,074,343 | -1.6% | 0.01% | -28.6% |
Q4 2021 | $91,079,000 | +38.9% | 12,274,823 | +6.1% | 0.01% | +40.0% |
Q3 2021 | $65,573,000 | -13.3% | 11,564,887 | +0.8% | 0.01% | -16.7% |
Q2 2021 | $75,624,000 | -31.0% | 11,475,530 | -15.2% | 0.01% | -33.3% |
Q1 2021 | $109,627,000 | +35.5% | 13,534,350 | +7.9% | 0.01% | +28.6% |
Q4 2020 | $80,900,000 | +1327.8% | 12,542,614 | +696.8% | 0.01% | +600.0% |
Q3 2020 | $5,666,000 | -21.7% | 1,574,061 | +0.0% | 0.00% | 0.0% |
Q2 2020 | $7,240,000 | +34.9% | 1,573,863 | +0.0% | 0.00% | 0.0% |
Q1 2020 | $5,366,000 | +39.6% | 1,573,748 | +108.9% | 0.00% | – |
Q4 2019 | $3,845,000 | +384400.0% | 753,199 | +171081.6% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 440 | +21.9% | 0.00% | – |
Q2 2019 | $1,000 | -100.0% | 361 | -100.0% | 0.00% | -100.0% |
Q1 2019 | $4,598,000 | -85.1% | 1,696,894 | -73.6% | 0.00% | -75.0% |
Q4 2018 | $30,855,000 | -56.5% | 6,427,984 | -14.3% | 0.00% | -50.0% |
Q3 2018 | $71,002,000 | -16.2% | 7,497,597 | -13.9% | 0.01% | -20.0% |
Q2 2018 | $84,692,000 | +23.9% | 8,704,234 | +34.0% | 0.01% | +25.0% |
Q1 2018 | $68,332,000 | +90.2% | 6,495,438 | +15.9% | 0.01% | +100.0% |
Q4 2017 | $35,930,000 | -16.2% | 5,605,285 | 0.0% | 0.00% | -20.0% |
Q3 2017 | $42,880,000 | +7.6% | 5,605,285 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $39,854,000 | +1184.0% | 5,605,285 | +598.9% | 0.01% | – |
Q1 2017 | $3,104,000 | +89.7% | 802,029 | 0.0% | 0.00% | – |
Q4 2016 | $1,636,000 | -72.2% | 802,029 | -63.4% | 0.00% | -100.0% |
Q3 2016 | $5,878,000 | -40.7% | 2,193,246 | -31.9% | 0.00% | 0.0% |
Q2 2016 | $9,917,000 | -78.9% | 3,219,829 | -41.6% | 0.00% | -85.7% |
Q1 2016 | $46,985,000 | -43.0% | 5,514,629 | -9.3% | 0.01% | -36.4% |
Q4 2015 | $82,461,000 | +18.4% | 6,076,729 | -16.3% | 0.01% | +10.0% |
Q3 2015 | $69,669,000 | -45.9% | 7,257,201 | -19.0% | 0.01% | -41.2% |
Q2 2015 | $128,838,000 | +58.4% | 8,959,497 | -1.4% | 0.02% | +70.0% |
Q1 2015 | $81,347,000 | +41.6% | 9,089,083 | -3.5% | 0.01% | +42.9% |
Q4 2014 | $57,442,000 | -47.1% | 9,416,641 | -8.2% | 0.01% | -53.3% |
Q3 2014 | $108,656,000 | -21.2% | 10,260,241 | -11.9% | 0.02% | -16.7% |
Q2 2014 | $137,945,000 | -24.2% | 11,640,950 | -4.5% | 0.02% | -28.0% |
Q1 2014 | $181,973,000 | +1.9% | 12,188,461 | +0.1% | 0.02% | 0.0% |
Q4 2013 | $178,618,000 | -17.7% | 12,175,738 | -4.5% | 0.02% | -24.2% |
Q3 2013 | $217,093,000 | +3.2% | 12,755,138 | +0.6% | 0.03% | -2.9% |
Q2 2013 | $210,362,000 | – | 12,680,071 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |